SCHEMBL18124136

SCHEMBL18124136

COc1ccc(-c2ccc(CCC(=O)O)n2-c2ccc(C(=O)Nc3ccc(OC)nc3)cc2C)cc1.COc1ccc(NC(=O)c2ccc(-n3c(CCC(=O)O)ccc3-c3ccc(Br)cc3)c(C)c2)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH5 P11766 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPT P10636 10/20 0.47
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
KDM4E B2RXH2 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
F2 P00734 1/20 0.47
ATM Q13315 1/20 0.47
PTGS1 P23219 1/20 0.47
PTGS2 P35354 1/20 0.47
TP53 P04637 3/20 0.46
POLB P06746 1/20 0.45
ALDH1A1 P00352 4/20 0.44
LMNA P02545 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ALOX12 P18054 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL245223 0.97 ADH5 (0.51) ADH5CYP2C19MAPTMEN1KMT2A
SCHEMBL243144 0.96 ADH5 (0.51) ADH5CYP2C19MAPTMEN1KMT2A
SCHEMBL1976466 0.84 ADH5 (0.52) ADH5CYP2C19MAPTMEN1KMT2A
SCHEMBL244392 0.84 MAPT (0.52) ADH5CYP2C19MAPTMEN1KMT2A
SCHEMBL239456 0.84 ADH5 (0.53) ADH5CYP2C19MAPTMEN1KMT2A
SCHEMBL243613 0.83 ADH5 (0.54) ADH5CYP2C19MAPTMEN1KMT2A
SCHEMBL248186 0.82 ADH5 (0.55) ADH5CYP2C19MAPTMEN1KMT2A
SCHEMBL243477 0.82 ADH5 (0.56) ADH5CYP2C19MAPTMEN1KMT2A
SCHEMBL242620 0.80 MAPT (0.59) ADH5CYP2C19MAPTMEN1KMT2A
SCHEMBL242957 0.78 ADH5 (0.62) ADH5CYP2C19MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318006-B1 NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS NIVALIS THERAPEUTICS INC (US) 2016-10-12 EP claimed